Literature DB >> 6604619

Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion.

J N Hunt, J L Smith, C L Jiang, L Kessler.   

Abstract

Twelve healthy subjects were given aspirin (975 mg four times a day) for four days. On days three and four, each dose of aspirin was preceded by a synthetic protaglandin E1 analog (misoprostol, Searle) either 25 micrograms, 50 micrograms, or placebo in a double-blind balanced full crossover design. Bleeding, gastric secretion of acid and chloride, and accumulation of gastric luminal DNA and calcium as indices of cell shedding and mucus secretion were measured by three daily morning gastric washouts, corrected for gastric emptying. Both bleeding and gastric secretion were greater on day 4 with aspirin and placebo than on day 0. With 50 micrograms misoprostol, and to a lesser extent with 25 micrograms, bleeding and gastric secretion were reduced on day 4 compared to day 4 with placebo or aspirin only days. The reduction in gastric bleeding with the 50-microgram dosage of misoprostol was directly related to the reduction in acid secretion. The ratios of changes in acid and chloride outputs did not indicate any increase in bicarbonate secretion. No changes in the recoveries of calcium or DNA were seen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604619     DOI: 10.1007/bf01317040

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Studies on the acid secretion that occurs during injury to the gastric mucosa.

Authors:  M R Thompson
Journal:  Gastroenterology       Date:  1976-08       Impact factor: 22.682

Review 2.  The action of analgesic substances on the gastric mucosa. Clinical effects on the gut of ingestion of aspirin, phenylbutazone, indomethacin and paracetamol.

Authors:  D N Croft
Journal:  J Pharm Pharmacol       Date:  1966-06       Impact factor: 3.765

3.  Gastric mucosa and susceptibility to occult gastrointestinal bleeding caused by aspirin.

Authors:  D N Croft; P H Wood
Journal:  Br Med J       Date:  1967-01-21

4.  A comparison of the effects of prostacyclin and the 15(S), 15-methyl analogs of PGE2 and PGF2-alpha on gastric parietal and nonparietal secretion.

Authors:  P T Shea-Donohue; D Nompleggi; L Myers; A Dubois
Journal:  Dig Dis Sci       Date:  1982-01       Impact factor: 3.199

5.  Salicylate damage to the gastric mucosal barrier.

Authors:  H W Davenport
Journal:  N Engl J Med       Date:  1967-06-08       Impact factor: 91.245

6.  SC-29333: a potent inhibitor of canin gastric secretion.

Authors:  E Z Dajani; D R Driskill; R G Bianchi; P W Collins; R Pappo
Journal:  Am J Dig Dis       Date:  1976-12

7.  Effect of prostaglandin E2 on gastric mucosal bleeding caused by aspirin.

Authors:  J N Hunt; D R Franz
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

8.  Increased resistance of the gastric mucosal barrier to barrier breakers in the rat.

Authors:  J Deregnaucourt; C F Code
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

9.  PGE2 stimulates gastric chloride transport: possible key to cytoprotection.

Authors:  R Schiessel; J Matthews; A Barzilai; A Merhav; W Silen
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

10.  Gastric bicarbonate secretion: effect of topical and intravenous 16,16-dimethyl prostaglandin E2.

Authors:  G L Kauffman; J J Reeve; M I Grossman
Journal:  Am J Physiol       Date:  1980-07
View more
  28 in total

Review 1.  Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management.

Authors:  S Szabo; W F Spill; K D Rainsford
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

2.  A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients.

Authors:  D Rachmilewitz; J W Chapman; P A Nicholson
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

3.  Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer.

Authors:  J E McGuigan; Y Chang; E Z Dajani
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

4.  Misoprostol-induced increases in adherent gastric mucus thickness and luminal mucus output.

Authors:  L A Sellers; N J Carroll; A Allen
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

5.  Effects of misoprostol on gastric acid and mucus secretion in man.

Authors:  D E Wilson; E Quadros; T Rajapaksa; A Adams; M Noar
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

Review 6.  Overview of misoprostol clinical experience.

Authors:  R L Herting; C H Nissen
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

7.  Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.

Authors:  F E Silverstein; M B Kimmey; D R Saunders; D S Levine
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

8.  A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects.

Authors:  F L Lanza
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

9.  The pathophysiology of peptic ulcer disease.

Authors:  F P Brooks
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

10.  Prostaglandins in peptic ulcer disease. An overview of current status and future directions.

Authors:  S J Sontag
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.